Depomed seeks FDA approval of Serada

Depomed Inc. (NASDAQ:DEPO) submitted an NDA to FDA for Serada extended-release gabapentin tablets to treat menopausal hot flashes. Serada uses the company's Acuform delivery technology. Depomed, which...